Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters








Database
Language
Publication year range
1.
J R Soc Interface ; 16(155): 20180966, 2019 06 28.
Article in English | MEDLINE | ID: mdl-31213177

ABSTRACT

Non-equilibrium atmospheric-pressure plasmas are an alternative means to sterilize and disinfect. Plasma-mediated protein aggregation has been identified as one of the mechanisms responsible for the antibacterial features of plasma. Heat shock protein 33 (Hsp33) is a chaperone with holdase function that is activated when oxidative stress and unfolding conditions coincide. In its active form, it binds unfolded proteins and prevents their aggregation. Here we analyse the influence of plasma on the structure and function of Hsp33 of Escherichia coli using a dielectric barrier discharge plasma. While most other proteins studied so far were rapidly inactivated by atmospheric-pressure plasma, exposure to plasma activated Hsp33. Both, oxidation of cysteine residues and partial unfolding of Hsp33 were observed after plasma treatment. Plasma-mediated activation of Hsp33 was reversible by reducing agents, indicating that cysteine residues critical for regulation of Hsp33 activity were not irreversibly oxidized. However, the reduction yielded a protein that did not regain its original fold. Nevertheless, a second round of plasma treatment resulted again in a fully active protein that was unfolded to an even higher degree. These conformational states were not previously observed after chemical activation with HOCl. Thus, although we could detect the formation of HOCl in the liquid phase during plasma treatment, we conclude that other species must be involved in plasma activation of Hsp33. E. coli cells over-expressing the Hsp33-encoding gene hslO from a plasmid showed increased survival rates when treated with plasma while an hslO deletion mutant was hypersensitive emphasizing the importance of protein aggregation as an inactivation mechanism of plasma.


Subject(s)
Escherichia coli Proteins/chemistry , Escherichia coli Proteins/metabolism , Escherichia coli/growth & development , Heat-Shock Proteins/chemistry , Heat-Shock Proteins/metabolism , Plasma Gases/chemistry , Protein Aggregates , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Heat-Shock Proteins/genetics , Oxidation-Reduction
2.
Proteomics Clin Appl ; 10(9-10): 1036-1048, 2016 10.
Article in English | MEDLINE | ID: mdl-27329548

ABSTRACT

PURPOSE: Trimethoprim is a folate biosynthesis inhibitor. Tetrahydrofolates are essential for the transfer of C1 units in several biochemical pathways including purine, thymine, methionine, and glycine biosynthesis. This study addressed the effects of folate biosynthesis inhibition on bacterial physiology. EXPERIMENTAL DESIGN: Two complementary proteomic approaches were employed to analyze the response of Bacillus subtilis to trimethoprim. Acute changes in protein synthesis rates were monitored by radioactive pulse labeling of newly synthesized proteins and subsequent 2DE analysis. Changes in protein levels were detected using gel-free quantitative MS. RESULTS: Proteins involved in purine and histidine biosynthesis, the σB -dependent general stress response, and sporulation were upregulated. Most prominently, the PurR-regulon required for de novo purine biosynthesis was derepressed indicating purine depletion. The general stress response was activated energy dependently and in a subpopulation of treated cultures an early onset of sporulation was observed, most likely triggered by low guanosine triphosphate levels. Supplementation of adenosine triphosphate, adenosine, and guanosine to the medium substantially decreased antibacterial activity, showing that purine depletion becomes the bottleneck in trimethoprim-treated B. subtilis. CONCLUSIONS AND CLINICAL RELEVANCE: The frequently prescribed antibiotic trimethoprim causes purine depletion in B. subtilis, which can be complemented by supplementing purines to the medium.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacillus subtilis/drug effects , Bacillus subtilis/metabolism , Purines/biosynthesis , Trimethoprim/pharmacology , Adenosine/pharmacology , Adenosine Triphosphate/pharmacology , Bacillus subtilis/physiology , Bacterial Proteins/metabolism , Energy Metabolism/drug effects , Guanosine/pharmacology , Proteomics , Spores, Bacterial/drug effects , Spores, Bacterial/physiology , Stress, Physiological/drug effects
3.
Chembiochem ; 16(7): 1101-8, 2015 May 04.
Article in English | MEDLINE | ID: mdl-25821129

ABSTRACT

The mechanism of action of aurein 2.2 and aurein 2.3, antimicrobial peptides from the frog Litoria aurea, was investigated. Proteomic profiling of the Bacillus subtilis stress response indicates that the cell envelope is the main target for both aureins. Upon treatment, the cytoplasmic membrane depolarizes and cellular ATP levels decrease. Global element analysis shows that intracellular concentrations of certain metal ions (potassium, magnesium, iron, and manganese) strongly decrease. Selective translocation of some ions over others was demonstrated in vitro. The same set of ions also leaks from B. subtilis cells treated with sublethal concentrations of gramicidin S, MP196, and nisin. Aureins do not permeabilize the cell membrane for propidium iodide thus excluding formation of large, unspecific pores. Our data suggest that the aureins acts by forming small pores thereby causing membrane depolarization, and by triggering the release of certain metal ions thus disturbing cellular ion homeostasis.


Subject(s)
Antimicrobial Cationic Peptides/pharmacology , Bacillus subtilis/drug effects , Bacillus subtilis/metabolism , Amino Acid Sequence , Animals , Antimicrobial Cationic Peptides/chemistry , Anura , Bacillus subtilis/cytology , Cell Membrane/drug effects , Homeostasis/drug effects , Molecular Sequence Data , Porosity , Proteomics
4.
ACS Chem Biol ; 8(7): 1442-50, 2013 Jul 19.
Article in English | MEDLINE | ID: mdl-23578171

ABSTRACT

Two hetero-tri-organometallic compounds with potent activity against Gram-positive bacteria including multi-resistant Staphylococcus aureus (MRSA) were identified. The compounds consist of a peptide nucleic acid backbone with an alkyne side chain, substituted with a cymantrene, a (dipicolyl)Re(CO)3 moiety, and either a ferrocene (FcPNA) or a ruthenocene (RcPNA). Comparative proteomic analysis indicates the bacterial membrane as antibiotic target structure. FcPNA accumulation in the membrane was confirmed by manganese tracing with atomic absorption spectroscopy. Both organometallics disturbed several essential cellular processes taking place at the membrane such as respiration and cell wall biosynthesis, suggesting that the compounds affect membrane architecture. Correlating with enhanced antibacterial activity, oxidative stress was induced only by the ferrocene-substituted compound. The organometallics described here target the cytoplasmic membrane, a clinically proven antibacterial target structure, feature a bactericidal but non-bacteriolytic mode of action and limited cytotoxicity within the limits of solubility. Thus, FcPNA represents a promising lead structure for the development of a new synthetic class of antibiotics.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Organometallic Compounds/chemistry , Organometallic Compounds/pharmacology , Animals , Cell Line , Cell Line, Tumor , Humans , Inhibitory Concentration 50 , Microbial Sensitivity Tests , Peptide Nucleic Acids/chemistry , Peptide Nucleic Acids/pharmacology , Proteomics , Spectrophotometry, Atomic
SELECTION OF CITATIONS
SEARCH DETAIL